Pain Management Devices Market Growth Report | Global Forecasts 2027

Pain Management Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Neuromodulation Devices, Ablation Devices, Analgesic Infusion Pumps); Application (Neuropathic Pain, Cancer Pain, Facial Pain and Migraine, Musculoskeletal Pain, Others); and Geography

Publication Month : May 2020

  • Report Code : TIPHE100000860
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The pain management devices market is expected to reach US$ 8,388.67 million in 2027 from US$ 4,527.31 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.

Market Insights and Analyst View:

Pain management devices control or manage the pain caused by arthritis, an old injury, and cancer treatments. Devices are used according to the individual's difficulty due to the pain; the devices are available in hospitals and can be used during pain management therapy or bought over the counter. Pain management devices are used for the implantation, replacement, or other surgical management of a device required to treat pain. Infusion pumps or neurostimulator are used to treat nerve pain and chest pain caused by coronary heart diseases. The demand for pain management devices is continuously growing due to the increasing chronic pain incidence rate, rising product launches, and growing geriatric population.

Growth Drivers and Challenges:

The increasing incidences of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and musculoskeletal diseases are likely to drive the growth of the pain management devices market. These diseases critically affect a person's health by lowering immunity and resulting in chronic pain. Chronic pain is most commonly seen in adults and geriatric populations. For instance, according to the Centers for Disease Control and Prevention, during 2021, an estimated 20.9% of U.S. adults (51.6 million persons) experienced chronic pain, and 6.9% (17.1 million persons) experienced high-impact chronic pain.

Nevertheless, chronic pain diseases are also noticeable among children. Furthermore, incidences of chronic pain are commonly seen among athletes, sportspersons, and people living with past injuries. Chronic pain incidences increase a person's dependency on others for various daily tasks. Therefore, pain management is essential to carry out a normal daily routine. Pain management devices relieve longer durations and improve their health. A wearable pain management device is easy to use and operate; thus, it reduces the person's dependency on others. Therefore, due to pain management devices' advantages, the demand is rising among patients with chronic diseases.   

One challenge is the lack of awareness of pain management through therapy and devices among people in low- and middle-income countries. For instance, most people in APAC, the MEA, and Latin America reside in rural parts. There is a lack of communication, accessibility, and knowledge sharing about medical technologies to the masses. Due to the lack of awareness about pain management devices, most people consume analgesic medicines to treat chronic pain. In addition, analgesic medicine is easily available as an OTC drug and at a low price. Therefore, the shift toward medicinal products is more than pain management devices.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Pain Management Devices Market: Strategic Insights

pain-management-devices-market
Market Size Value inUS$ 4,527.31 Million in 2019
Market Size Value byUS$ 8,388.67 Million by 2027
Growth rateCAGR of 8.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Global Pain Management Devices Market” is segmented based on product type and application. Based on product type, the pain management devices market is segmented into neuromodulation devices, ablation devices, and analgesic infusion pumps. In terms of application, the pain management devices market is divided into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others. The pain management devices market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

The pain management devices market, by product type, is segmented into neuromodulation devices, ablation devices, and analgesic infusion pumps. The neuromodulation devices segment held the largest share of the market in 2019. However, the ablation devices segment is estimated to register the highest CAGR in the market during the forecast period. Neuromodulation devices are technically advanced and designed to treat hemicrania attacks and cluster headaches. The devices suppress the nervous system activities to reduce pain. A neuromodulation device utilizes electrical currents or magnets to control signaling activity in the brain. A neuromodulation device is often known as a neurostimulator and has two types, such as portable and implantable. The FDA has issued a few approvals for neuromodulation devices to treat migraines. Various big and small medical device companies are focusing on this segment. For instance, Abbott and Medtronic offer implantable neurostimulation devices, whereas few companies have launched portable neuromodulation devices to treat chronic pain. The segment is divided into transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) devices.

The neuromodulation devices are further bifurcated into spinal cord stimulators (SCS) and transcutaneous electrical nerve stimulation (TENS) devices.

Procedure Trays Market, by Product Type – 2019 and 2027

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Based on application, the pain management devices market is divided into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others. The neuropathic pain segment held the largest share of the market in 2019. However, the musculoskeletal pain segment is estimated to register the highest CAGR in the market during the forecast period.

Regional Analysis:

Based on geography, the pain management devices market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The market in North America has been analyzed with a prime focus on three major countries—the US, Canada, and Mexico. The North American region is the largest pain management device market. The factors that have enabled the North America region to be the largest market include the increasing number of patients suffering from pain due to chronic diseases, increasing competition between the market players,  needing pain management devices, high R&D spending to develop new therapeutic products and sophisticated infrastructure. In North America, the US is the largest market for pain management devices. In the US, chronic lower back pain is one of the most common chronic conditions. Chronic pain may inhibit daily activities or mobility and has been linked to poor perceived health, anxiety and depression, and dependence on opioids.

In 2019, Asia Pacific registered as the fastest-growing global pain management devices market. The market's growth is expected to be fastest owing to the factors such as the rising need for devices due to the high prevalence of cancer and diabetes patients, rapidly improving healthcare infrastructure, growing government support, and the increasing number of startups in this region. In addition, in the last few years, companies in China are developing pain relief patches for different medical conditions. For instance, Shandong Zhushitang Medical Devices Co., Ltd offers Prostate Heat Patch for patients with prostatic hyperplasia, low sexual function, frequent urination, odynuria, urgent urination, prostatitis, and kidney deficiency. Similarly, Shanghai Lumsail Industrial Inc offers cold laser therapy for Pain Relief in patients with arthritis, neck and back pain, migraines, sinusitis, and others.

Procedure Trays Market Opportunity:

The development in the medical sector has enabled the introduction of neurostimulation devices to treat chronic pain. Various companies, such as Abbott, Medtronic, and Omron Healthcare, Inc, have launched neurostimulation devices. Also, various companies have shifted their focus to neurostimulation therapy. The neurostimulation therapy alters the pain signals while traveling toward the brain. During the therapy, the device delivers electrical stimulation to the brain, dorsal root ganglion, and spinal cord. The electrical stimulation helps to relax the muscles and reduces pain to a greater extent.

Neurostimulation has progressed over the last few decades from a low-resolution approach to a highly sophisticated methodology involving state-of-the-art technologies. Neurostimulation has been tested for many neurological applications, indicating great promise and attracting growing attention in academia and industry. Neurostimulation is used in many medical technologies, with some devices already approved for clinical use. The field of neurostimulation developed hand-in-hand with advances in other fields. Adopting emerging technologies, such as wireless energy transfer, silicon micro-fabrication, hermetic packaging, application-specific integrated circuit (ASIC) technology, flexible electronics and many more, assisted in the field's rapid development.

Neurostimulation therapy is an innovative technology that will likely have wider growth opportunities in the coming years. In March 2021, a non-invasive multi-channel brain neuromodulation system was approved for acute migraine treatment. The device is worn as a headset and targets multiple nerves on the head. It has been shown to reduce pain and other migraine-related symptoms like sensitivity to light and sound. 

Competitive Landscape and Key Companies:

Some prominent players operating in the global pain management devices market are Medtronic plc, ST. Jude Medical, Inc., Boston Scientific Corporation, Hospira, Inc., Halyard Health Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech NA, Inc., BD, and Nevro Corp. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. The companies implementing various inorganic and organic developments in the global pain management devices market. Below are a few instances:

  • In December 2022, Abbott received the U.S. Food and Drug Administration (FDA) approval for Eterna spinal cord stimulation (SCS) system – the smallest implantable, rechargeable spinal cord stimulator currently available for treating chronic pain.
  • In July 2022, The U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to investigate the use of its deep brain stimulation (DBS) system (Abbott) in treatment-resistant depression (TRD), a form of major depressive disorder (MDD). Abbott's DBS system is a personalized, adjustable therapy that involves implanting thin wires or leads into targeted brain areas. A pulse generator implanted under the skin in the chest is connected to the leads and produces electrical impulses that can modulate abnormal brain activity. 
  • In June 2022, CoachCare, a leading remote patient monitoring (RPM) and virtual health company partnered with NXTSTIM to provide the first-ever commercial RPM solution for pain management. NXTSTIM EcoAI provides personalized pain therapy with comprehensive pain relief, strengthening, and relaxation. It makes achieving pain relief much easier, simpler, and more enjoyable. 
  • In July 2021, FDA approved Senza Spinal Cord Stimulation System – P130022/S039. Senza Spinal Cord Stimulation (SCS) system  is an implanted, rechargeable spinal cord stimulation system intended to treat long-term (chronic) pain in the trunk or limbs that are difficult to manage (intractable). The SCS system is used to manage chronic pain in the trunk or limbs, including one-sided or two-sided pain associated with failed back surgery syndrome, intractable low back pain, leg pain, and nerve damage caused by diabetes (diabetic neuropathy).
  • In December 2020, The WaveWriter Alpha SCS Systems were approved by the U.S. Food and Drug Administration and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with failed back surgery syndrome, Complex Regional Pain Syndrome Types I and II, intractable low back pain and leg pain.
  • In February 2020, Avanos Medical, Inc. received approval from the U.S. Food and Drug Administration (FDA) for marketing of its new, 80-Watt COOLIEF Radiofrequency (RF) system for neurological lesion procedures. This new device is easy-to-use, equipped with an advanced designed RF generator and other associated devices. Cooled RF is a non-opioid, minimally invasive outpatient pain management procedure that uses cooled radiofrequency energy to safely treat chronic pain by targeting the sensory nerves causing pain.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type ; Application ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are the driving factors for the pain management devices market across the globe?

The growth of the market is attributed to some key driving factors such as, increasing prevalence of chronic pain, increasing number of product launches and growing geriatric population. However, lack of awareness about pain management and high cost associated with it is likely to hamper the market growth. Additionally, technological advancements in these devices is expected to influence the market growth in the forecast period.

What is the average cost of a cryoablation procedure?

Cryoablation technologies are expensive and require argon gas which is not readily available in developing countries. The single treatment cost of cryoablation is around USD 10,000. However, the cost of a cryoablation procedure may vary with region and type.

What are Pain Management Devices?

Chronic or acute pain due to diseases like cancer, diabetes, arthritis and others can be reduced or controlled through pain management therapy. The pain management specialist treats the patients pain through prescribing medicines, physical therapy, devices, rehabilitation, and counseling. Medical devices used to treat chronic as well as acute pain are termed as pain management devices. It is widely used to treat and control neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others.

The List of Companies - Pain Management Devices Market

  1. Medtronic plc 
  2. Abbott
  3. Boston Scientific Corporation 
  4. Hospira  Inc. 
  5. Halyard Health  Inc 
  6. Smiths Medical 
  7. B. Braun Melsungen AG 
  8. Neurotech NA  Inc. 
  9. BD 
  10. Nevro Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pain Management Devices Market